SBIR/STTR Research Award

Multi Scale In Vitro D Tissue Model of Vascularized Bone Cartilage Interactions

Award identifier 3d335fd619baae8d5cdde19ba0669df5b8aac1a76f0434947c52cd91b3531069Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$225,000

Program and phase

SBIR · Phase I

Award year

2017

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
CFD Research Corporation
Proposal award date
2017-09-19
Contract end date
2019-05-31
UEI
V3KCP1HNFM33
Solicitation number
AR17-005
Topic code
NIAMS

Research abstract

Abstract Current in vitro models of vascularized bone tissues do not mimic the in vivo microenvironment comprising of diverse cell types in communication with each other through stromal barriers In addition they are hampered by lack of real time visualization and quantitation of vasculature bone as well as bone cartilage interactions In contrast animal models while providing useful information are time consuming expensive and in recent years have increasingly raised ethical concerns Furthermore animal studies provide limited understanding of mechanistic behavior compared to well controlled in vitro studies Thus there is an unmet need for an in vitro platform for improved monitoring and analysis of vascularized bone cartilage interactions We propose to develop and demonstrate a multi scale model of vascularized bone cartilage tissue for the understanding of cellular signaling with a Phase I focus on the interactions between endothelial cells bone cells specifically osteoblasts bone building cells and osteoclasts bone degrading cells and chondrocytes cartilage cells The multi scale nature of the proposed approach is based on the use of a a microscale based vascular bone cartilage model using microfluidics and tissue engineering to study cell signaling which informs b a meso scale vascular bone cartilage model interrogating both engineered constructs and native tissues for structural and functional studies Phase I will clearly and unequivocally demonstrate the use of this multiscale model of vascularized osteochondral tissue interactions for cell signaling The developed platform will mimic the morphology physiological flow and D multi cellular compositions observed in vivo and enable an easy and robust system for evaluation of cellular responses In Phase II the platform will be expanded to include other stromal cells e g fibroblasts and immune cells e g macrophages followed by detailed characterization of the signaling molecules and therapeutic screening A multi disciplinary industry academic partnership with expertise in microfluidics cell based assays and musculoskeletal biology and tissue regeneration has been assembled for successful completion of this project By providing an accurate quantitative and predictive model of physiological interactions the developed multi scale platform promises to establish a new paradigm for in vitro assessment of the physiological response to therapeutics Narrative The overall objective of this study is to develop an in vitro D tissue model for understanding of vascularized bone cartilage interactions in both normal and diseased tissues The developed model will have critical applications both in basic research where it can be used to understand vascularized bone tissue interactions and in drug development where it can be used to screen for and develop next generation therapeutics

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

947 SBIR/STTR records share this UEI (1987–2026). Reported award amounts total $350,893,199. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Defense, National Aeronautics and Space Administration, Department of Health and Human Services, National Science Foundation, Department of Commerce, Department of Energy

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.